Miscarriage patients have fewer treatment options in states with abortion bans, study shows

A study in the Journal of the American Medical Association found that pregnant patients experiencing miscarriage in states with abortion bans have fewer treatment options, including a shift away from the recommended two-drug regimen (mifepristone and misoprostol) to less effective misoprostol-only treatments and increased use of expectant management. The study highlights risks like hemorrhage and infection due to reduced access to standard care.